Targeting Dysregulated Lipid Metabolism in Cancer with Pharmacological Inhibitors
- PMID: 38610991
- PMCID: PMC11010992
- DOI: 10.3390/cancers16071313
Targeting Dysregulated Lipid Metabolism in Cancer with Pharmacological Inhibitors
Abstract
Metabolic plasticity is recognised as a hallmark of cancer cells, enabling adaptation to microenvironmental changes throughout tumour progression. A dysregulated lipid metabolism plays a pivotal role in promoting oncogenesis. Oncogenic signalling pathways, such as PI3K/AKT/mTOR, JAK/STAT, Hippo, and NF-kB, intersect with the lipid metabolism to drive tumour progression. Furthermore, altered lipid signalling in the tumour microenvironment contributes to immune dysfunction, exacerbating oncogenesis. This review examines the role of lipid metabolism in tumour initiation, invasion, metastasis, and cancer stem cell maintenance. We highlight cybernetic networks in lipid metabolism to uncover avenues for cancer diagnostics, prognostics, and therapeutics.
Keywords: cancer stem cells; epigenetics; lipid signalling; metastasis; therapeutics.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures
References
-
- Bremer J., Osmundsen H. Chapter 5 Fatty Acid Oxidation and Its Regulation. In: Numa S., editor. New Comprehensive Biochemistry. Volume 7. Elsevier; Amsterdam, The Netherlands: 1984. pp. 113–154. Fattv Acid Metabolism and Its Regulation.
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous